Overall Survival After First-Line Niraparib Maintenance Therapy in Newly Diagnosed Advanced Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Ann. Oncol 2024 Sep 14;[EPub Ahead of Print], BJ Monk, MP Barretina-Ginesta, B Pothuri, I Vergote, W Graybill, MR Mirza, CC McCormick, D Lorusso, RG Moore, G Freyer, RE O'Cearbhaill, F Heitz, DM O'Malley, A Redondo, MS Shahin, C Vulsteke, WH Bradley, CA Haslund, DM Chase, C Pisano, LL Holman, MJR Pérez, P DiSilvestro, L Gaba, TJ Herzog, I Bruchim, N Compton, L Shtessel, IA Malinowska, A González-MartínFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.